Related Experiment Video

Updated: Jun 13, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.0K

[Rucaparib in maintenance in patients with newly diagnosed ovarian cancer]

Lucie Houdou1, Manuel Rodrigues2

  • 1Service d'oncologie-radiothérapie, hôpital Est-Francilien, 77600 Jossigny, France.

Bulletin Du Cancer
|September 11, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.6K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.2K

Related Experiment Videos

Last Updated: Jun 13, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.0K
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
04:07

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays

Published on: February 24, 2023

1.6K
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

12.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

Articles linked to this work by shared authors, journal, and citation graph.

Survival of Patients With MBD4-Mutated Metastatic Uveal Melanoma Treated With Immune Checkpoint Inhibitors.

Translational vision science & technology·2026

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Human PMS1-dependent non-canonical mismatch repair engages with MBD4 to repair methylated CpG deamination.

Nucleic acids research·2026

Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

Nature medicine·2026

Impact of feature engineering on predicting non-contact football injuries.

Scientific reports·2026

[Facing a patient's wish to hasten death in palliative care: Professionals' experiences, practices, and interactional adjustments].

Bulletin du cancer·2026

[Evolving strategies for relapsed multiple myeloma: Toward personalized treatment in 2026].

Bulletin du cancer·2026

[Informational stress among oncologists: an exploratory survey].

Bulletin du cancer·2026

[General practitioners' knowledge of anticancer immunotherapies and their adverse effects: A cross-sectional survey].

Bulletin du cancer·2026

[Factors associated with physical activity practice among adults living with cancer in the city of Ouagadougou].

Bulletin du cancer·2026

[Follow-up of the long-term survivors of transplantation and cellular therapy - SFGM-TC].

Bulletin du cancer·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us